Establishment Labs (NASDAQ:ESTA) Shares Down 5.9% – Should You Sell?

Establishment Labs Holdings Inc. (NASDAQ:ESTA)’s stock price was down 5.9% during trading on Wednesday . The stock traded as low as $44.05 and last traded at $43.49. Approximately 151,581 shares traded hands during mid-day trading, a decline of 63% from the average daily volume of 410,610 shares. The stock had previously closed at $46.20.

Analyst Upgrades and Downgrades

Separately, Stephens restated an “overweight” rating and set a $52.00 price target on shares of Establishment Labs in a research report on Thursday, February 27th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $57.40.

Establishment Labs Stock Performance

The company’s 50-day moving average is $37.55 and its two-hundred day moving average is $41.37. The company has a market capitalization of $1.24 billion, a P/E ratio of -17.19 and a beta of 1.12. The company has a quick ratio of 2.29, a current ratio of 3.62 and a debt-to-equity ratio of 5.94.

Establishment Labs (NASDAQ:ESTA) last issued its quarterly earnings results on Wednesday, February 26th. The company reported ($0.98) EPS for the quarter, missing analysts’ consensus estimates of ($0.64) by ($0.34). Establishment Labs had a negative return on equity of 184.55% and a negative net margin of 46.13%. The company had revenue of $44.51 million during the quarter, compared to the consensus estimate of $44.45 million. Equities analysts anticipate that Establishment Labs Holdings Inc. will post -2.41 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Establishment Labs

Several hedge funds have recently added to or reduced their stakes in ESTA. Quarry LP purchased a new position in shares of Establishment Labs during the 4th quarter valued at about $27,000. R Squared Ltd bought a new position in Establishment Labs during the fourth quarter valued at approximately $36,000. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of Establishment Labs during the third quarter worth approximately $127,000. KLP Kapitalforvaltning AS bought a new stake in shares of Establishment Labs in the 4th quarter worth approximately $161,000. Finally, Hood River Capital Management LLC boosted its stake in shares of Establishment Labs by 236.4% in the 4th quarter. Hood River Capital Management LLC now owns 5,920 shares of the company’s stock valued at $273,000 after purchasing an additional 4,160 shares in the last quarter. Institutional investors own 72.91% of the company’s stock.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.